Resumo:
En
|
Texto:
En
|
PDF:
En
Abstract Chemotherapy stands out as the main systemic treatment strategy against cancer and still faces problems related to multidrug resistance and severe side effects. Copper-based drugs have been widely explored in medicinal chemistry, since copper is an essential metal for physiological activities with antineoplastic effects. In this context, the present study aimed to evaluate the recombinogenic/mutagenic and anticarcinogenic potential of the complex CBP-01 - [Cu(bta)(1,10-phen)ClO4] (Hbta = 4,4,4-trifluoro-1-phenyl-1,3-butanedione and 1,10-phen =1,10-phenanthroline) - through the Somatic and Recombination test (SMART) and the Epithelial Tumor Test (ETT) in Drosophila melanogaster, compared with carboplatin (CARB) and cisplatin (CIS) effects. According to our results, CARB and CIS induced a high frequency of mutant spots, which was not verified at higher concentrations of CBP-01. In addition, CBP-01 exhibited mutagenic/recombinogenic potential only at the lowest concentration and after biometabolization. Subsequently, in the ETT test, CBP-01 did not demonstrate carcinogenic effect. Lastly, epithelial tumors were identified in flies treated with CARB and CIS, which were modulated by the CBP-01 complex. Therefore, CBP-01 modulates genotoxicity of other compounds and is a promising metal-based drug for the development of a new anticancer agent or for optimization of therapeutic regimens. effects Copperbased Copper based chemistry context recombinogenicmutagenic recombinogenic mutagenic CBP01 CBP 01 CBP-0 Cubta1,10phenClO4 Cubta110phenClO4 CubtaphenClO Cu bta 1,10 phen ClO4 1 10 ClO [Cu(bta)(1,10-phen)ClO4 Hbta 4,4,4trifluoro1phenyl1,3butanedione 444trifluoro1phenyl13butanedione trifluorophenylbutanedione 4,4,4 trifluoro phenyl 1,3 butanedione 4 3 1,10phen 110phen =1,10phenanthroline 110phenanthroline phenanthroline =1,10 =1,10-phenanthroline SMART (SMART (ETT melanogaster (CARB (CIS results spots CBP01. 01. addition mutagenicrecombinogenic biometabolization Subsequently effect Lastly Therefore metalbased regimens CBP0 0 CBP- Cubta1 10phenClO4 Cubta phenClO Cubta1,10phenClO Cubta110phenClO 110 1,1 [Cu(bta)(1,10-phen)ClO 4trifluoro1phenyl1 3butanedione 444 4,4, 13 1, 10phen 10phenanthroline =1,1 10phenClO 11 trifluorophenyl 4trifluoro1phenyl 44 4,4 =1, 4, =1